Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: Optimal cut-off point, diagnostic value and future opportunities in primary careFootnote

*Oral presentation at the annual research conference of the European Primary Care Cardiovascular Society (EPCCCS) in London, September 2013.

References

• Reimer KA, Jennings RB. The ‘wavefront phenomenon’ of myocardial ischemic cell death. II Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest. 1979;40:633–44.
   PubMed Web of Science ®Google Scholar
• Gersh BJ, Stone GW, White HD, Holmes DR Jr. Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: Is the slope of the curve the shape of the future? J Am Med Assoc. 2005;293:979–86.
   PubMed Web of Science ®Google Scholar
• McConaghy JR, Rupal S. Outpatient diagnosis of acute pain in adults. Am Fam Physician 2013;87:177–82.
   PubMed Web of Science ®Google Scholar
• Bruyninckx R, Aertgeerts B, Bruyninckx P, Buntinx F. Signs and symptoms in diagnosing acute myocardial infarction and acute coronary syndrome: A diagnostic meta-analysis. Br J Gen Pract. 2008;58:105–11.
   PubMed Web of Science ®Google Scholar
• Body R, Carley S, Wibberley C, McDowell G, Ferguson J, Mackway-Jones K. The value of symptoms and signs in the emergent diagnosis of acute coronary syndromes. Resuscitation 2010;81:281–6.
   PubMed Web of Science ®Google Scholar
• Rutten FH, Kessels AG, Willems FF, Hoes AW. Electrocardiography in primary care: Is it useful? Int J Cardiol. 2000;74:199–205.
   PubMed Web of Science ®Google Scholar
• Bruins Slot MH, Rutten FH, Van der Heijden GJ, Doevendans PA, Mast EG, Bredero AC, et al. Diagnostic value of a heart-type fatty acid-binding protein (H-FABP) bedside test in suspected acute coronary syndrome in primary care. Int J Cardiol. 2013; 168:1485–9.
   PubMed Web of Science ®Google Scholar
• Nilsson S, Scheike M, Engblom D, Karlsson LG, Mölstad S, Akerlind I, et al. Chest pain and ischaemic heart disease in primary care. Br J Gen Pract. 2003;53:378–82.
   PubMed Web of Science ®Google Scholar
• Bruins Slot MH, Rutten FH, Van der Heijden GJ, Geersing GJ, Glatz JF, Hoes AW. Diagnosing acute coronary syndrome in primary care: Comparison of the physicians’ risk estimation and a clinical decision rule. Fam Pract. 2011;28:323–8.
   PubMed Web of Science ®Google Scholar
• Newby LK, Jesse RL, Babb JD, Christenson RH, De Fer TM, Diamond GA, et al. ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: A report of the American College of Cardiology Foundation task force on clinical expert consensus documents. J Am Coll Cardiol. 2012;60:2427–63.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD: the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Circulation 2012;126:2020–35.
   PubMed Web of Science ®Google Scholar
• Nilsson S, Andersson PO, Borgquist L, Grodzinsky E, Janzon M, Kvick M, et al. Point-of-care troponin T testing in the management of patients with chest pain in the Swedish primary care. Int J Family Med. 2013; doi: 10.1155/2013/532093. Epub 10 January 2013.
   Google Scholar
• Glatz JF, Renneberg R. Added value of heart-type fatty acid- binding protein as plasma marker for the early evaluation of suspected acute coronary syndrome. Clin Lipidol. 2014;9: 205–20.
   Web of Science ®Google Scholar
• Dekker MS, Mosterd A, van ‘t Hof AW, Hoes AW. Novel biochemical markers in suspected acute coronary syndrome: Systematic review and critical appraisal. Heart 2010;96:1001–10.
   PubMed Web of Science ®Google Scholar
• Glatz JF, van der Vusse GJ, Simoons ML, Kragten JA, van Dieijen-Visser MP, Hermens WT. Fatty acid-binding protein and the early detection of acute myocardial infarction. Clin Chim Acta. 1998; 272:87–92.
   PubMed Web of Science ®Google Scholar
• Mad P, Domanovits H, Fazelnia C, Stiassny K, Russmuller G, Cseh A, et al. Human heart-type fatty-acid-binding protein as a point-of-care-test in the early diagnosis of acute myocardial infarction. QJM 2007;100:203–10.
   PubMed Web of Science ®Google Scholar
• McMahon CG, Lamont JV, Curtin E, McConnell RI, Crockard M, Kurth MJ, et al. Diagnostic accuracy of heart-type fatty acid- binding protein for the early diagnosis of acute myocardial infarction. Am J Emerg Med. 2012;30:267–74.
   PubMed Web of Science ®Google Scholar
• Carroll C, Al Khalaf M, Stevens JW, Leaviss J, Goodacre S, Collinson PO, et al. Heart-type fatty acid binding protein as an early marker for myocardial infarction: Systematic review and meta-analysis. Emerg Med J. 2013;30:280–6.
   PubMed Web of Science ®Google Scholar
• Collinson P, Gaze D, Goodacre S. Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain. Heart 2014;100:140–5.
   PubMed Web of Science ®Google Scholar
• Glatz JF, Mohren R. Plasma reference value of heart-type fatty acid-binding protein, the earliest available plasma biomarker of acute myocardial infarction. Health 2013;5:1206–9.
   Google Scholar
• Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2999–3054.
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre for Acute and Chronic Conditions. Chest pain of recent onset: NICE Guideline. http://www niceorg uk/nicemedia/live/12947/47938/47938 pdf (2010 NICE Clinical Guideline 95) (accessed 1 July 2014).
   Google Scholar
• Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012;33:2569–619.
   PubMed Web of Science ®Google Scholar
• Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, et al. Management of acute coronary syndromes. Variations in practice and outcome; findings from the global registry of acute coronary events (GRACE). Eur Heart J. 2002;23:1177–89.
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–43.
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: A systematic review. Ann Intern Med. 2004;140:189–202.
   PubMed Web of Science ®Google Scholar
• Mueller C. Biomarkers and acute coronary syndromes: An update. Eur Heart J. 2014;35:552–6.
   PubMed Web of Science ®Google Scholar
• Willemsen RTA, Buntinx F, Winkens B, Glatz JF, Dinant GJ. The value of signs, symptoms and plasma heart-type fatty acid-binding protein (H-FABP) in evaluating patients presenting with symptoms possibly matching acute coronary syndrome: Background and methods of a diagnostic study in primary care. BMC Fam Pract. 2014;15:203. doi:10.1186/s12875-014-0203-8.
   PubMed Web of Science ®Google Scholar